RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
RT @mtbastin: "Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse…
"Clinical pharmacist.. participation in bedside rounds has been shown to decrease mortality, ICU length of stay, and adverse drug events." yet--> The most common staffing change during COVID was decrease of in‐person pharmacist rounding
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACIE_EBMT: Adapting clinical pharmacy staffing models during the COVID‐19 pandemic: Lessons learned and considerations for future disa…
Adapting clinical pharmacy staffing models during the COVID‐19 pandemic: Lessons learned and considerations for future disaster planning - Thompson Bastin - - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library http
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
RT @JACCPJournal: How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy…
How pharmacy depts adapted their staffing models #COVID19 https://t.co/QTrsIAu8Wz @mtbastin @HeavnerPharmD @FND_pharmacy @ALittlefieldPh1 @karenccrx @ChrisAdamsRUrx @deepalipharmd @jackiepaige14 @LemieuxPharmD @lemieuxVUDINE @CRosePharmD @tigernole13 @hock
COVID-19 severely impacted our nations’s entire health care system. Click ⬇️ to learn about how pharmacy staffing models adapted to the pandemic. Lessons learned and considerations for future disaster planning. https://t.co/cRGlYIm2vK
Another COVID paper just published! Very timely in our second wave!
RT @HeavnerPharmD: Our group’s latest COVID-19 paper is out! 🤗 Huge props to @mtbastin (fearless leader in this project) for being a super…
RT @HeavnerPharmD: Our group’s latest COVID-19 paper is out! 🤗 Huge props to @mtbastin (fearless leader in this project) for being a super…
Great paper by a great group of thought leaders! #PharmICU
RT @CCPharmacists: Adapting Clinical Pharmacy Staffing Models During the COVID‐19 Pandemic: Lessons Learned and Considerations for Future D…
👍👍
Adapting Clinical Pharmacy Staffing Models During the COVID‐19 Pandemic: Lessons Learned and Considerations for Future Disaster Planning https://t.co/7gNTihPgHY
I am a total ENFJ (protagonist), and I love love love leading a group to a common goal. This team of pharmacists has inspired and energized me!! Love working with y’all. Onto the next one! ☝🏻
RT @HeavnerPharmD: Our group’s latest COVID-19 paper is out! 🤗 Huge props to @mtbastin (fearless leader in this project) for being a super…
Our group’s latest COVID-19 paper is out! 🤗 Huge props to @mtbastin (fearless leader in this project) for being a super mom, super researcher, super clinician, super educator, and super leader—all around super hero! https://t.co/y3boGKXuvC #PharmICU #T